Radiation-Induced Nephropathy in the Murine Model Is Ameliorated by Targeting Heparanase.

Abecassis, Alexia; Hermano, Esther; Sheva, Kim; Rubinstein, Ariel M; Elkin, Michael; Meirovitz, Amichay

Abecassis, Alexia; Hermano, Esther; Sheva, Kim; Rubinstein, Ariel M; Elkin, Michael; Meirovitz, Amichay.

Afiliación

Abecassis A; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.
Hermano E; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.
Sheva K; Legacy Heritage Oncology Center and Dr. Larry Norton Institute, Soroka University Medical Center, Be'er Sheva 84101, Israel.
Rubinstein AM; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.
Elkin M; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.
Meirovitz A; Hebrew University Medical School, Jerusalem 91120, Israel.

Biomedicines ; 11(3)2023 Feb 27.

Article en En | MEDLINE | ID: mdl-36979689

Palabras clave

extracellular matrix; heparanase; pelvic malignancies; radiation nephropathy; radiotherapy of cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Biomedicines Año: 2023 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google